AI Heart Age Calculator Predicts Death Risk Two Decades in Advance
Mayo Clinic study finds each five-year gap between AI-estimated cardiac age and actual age raises 20-year mortality risk by up to 61% in healthy older adults.
Illustration: AI-generated
Artificial intelligence applied to routine heart ultrasounds can predict which seemingly healthy older adults face elevated risk of death from cardiovascular disease and dementia up to 20 years later, according to research presented at the ESC Digital & AI Summit 2026. The findings mark the first time AI-derived cardiac age has demonstrated prognostic value in the general population rather than just patients already diagnosed with heart disease.
AI Detects Hidden Cardiac Aging in Community Population
Dr. Jeffrey G. Malins of Mayo Clinic in Rochester led a retrospective analysis of 568 community-dwelling adults aged 50 and older who underwent echocardiography between 2002 and 2004. The research team applied deep learning algorithms to the echocardiography clips to estimate each participant's cardiac age, then calculated the gap between AI-predicted heart age and chronological age.
Over 20 years of follow-up, the results revealed a striking mortality gradient. Each five-year increase in the cardiac age gap was associated with a 61% increase in combined cardiovascular and dementia-related mortality when adjusted for age and sex (HR 1.61; 95% CI 1.24-2.07; p<0.001). Even after accounting for body mass index and left ventricle ejection fraction—a standard measure of heart pumping efficiency—the association remained robust at 46% increased risk (HR 1.46; 95% CI 1.13-1.90; p=0.004).
From Specialty Care to Preventive Medicine
The study represents a significant expansion of AI cardiac aging research beyond cardiovascular disease populations. Previous investigations had demonstrated the predictive value of AI-estimated heart age primarily in patients already receiving specialty cardiac care, limiting the technology's applicability to broader preventive health strategies.
By validating the approach in community-dwelling adults without known cardiovascular disease at baseline, the Mayo Clinic findings suggest AI cardiac age assessment could become a mainstream risk stratification tool in primary care and general cardiology settings. The 20-year predictive horizon provides clinicians with quantifiable prognostic information that extends well beyond traditional echocardiographic metrics.
Clinical Implications and Limitations
The researchers acknowledged important limitations in their analysis. The study combined cardiovascular and dementia-related mortality as a single outcome, leaving unclear whether the cardiac age gap relates differently to these distinct disease processes. Separate analyses would help clarify the biological relationships underlying the mortality associations.
For healthcare providers, the findings offer potential for identifying asymptomatic patients who might benefit from earlier or more intensive preventive interventions, though prospective validation studies and evidence-based treatment protocols remain necessary before clinical implementation. The convergence of cardiovascular and cognitive health assessment in a single AI-derived biomarker reflects growing recognition of shared pathophysiology between heart disease and dementia, suggesting that cardiac age may serve as a window into broader biological aging processes affecting multiple organ systems.
Sources
Follow Health AI Central
Keep up with health AI where you already read
On LinkedIn
The day’s strongest health AI stories in your feed, one or two each weekday.
On Google
Choose Health AI Central as a preferred source, and Google is more likely to show our reporting in Top Stories.
Reporting & accountability
How we maintain accuracy
Health AI Central separates reported facts, analysis, and public-source data. Readers can review our standards, request a correction, or consult the relevant research methodology before relying on a claim.